Home/Filings/4/0001127602-24-007080
4//SEC Filing

Jobe James R 4

Accession 0001127602-24-007080

CIK 0000877860other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 3:19 PM ET

Size

11.0 KB

Accession

0001127602-24-007080

Insider Transaction Report

Form 4
Period: 2024-02-23
Jobe James R
Director
Transactions
  • Award

    Stock Option (Right to Buy) 2024

    2024-02-23+10,00010,000 total
    Exercise: $57.76From: 2024-02-23Exp: 2029-02-23Common Stock (10,000 underlying)
Holdings
  • Common Stock - Jointly held with spouse

    14,979
  • Common Stock - IRA SEP

    500
  • Stock Option (Right to buy) 2022

    Exercise: $53.41From: 2022-02-25Exp: 2027-02-25Common Stock (25,000 underlying)
    25,000
  • Stock Options (Right to Buy) 2-21-2020

    Exercise: $90.79From: 2020-02-21Exp: 2025-02-21Common Stock (25,000 underlying)
    25,000
  • Stock Options (Right to Buy) 2-25-2021

    Exercise: $69.20From: 2021-02-25Exp: 2026-02-25Common Stock (25,000 underlying)
    25,000
  • Stock Option (Right to Buy) 2023

    Exercise: $54.73From: 2023-02-24Exp: 2028-02-24Common Stock (10,000 underlying)
    10,000

Issuer

NATIONAL HEALTH INVESTORS INC

CIK 0000877860

Entity typeother

Related Parties

1
  • filerCIK 0001362322

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 3:19 PM ET
Size
11.0 KB